Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 3
Submit an article Journal homepage
140
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Comorbidity burden and outcomes of older adults with acute promyelocytic leukemia: a National Cancer Database analysis of 2221 patients

Prajwal Dhakala Department of Internal Medicine, Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA, USAORCID Iconhttps://orcid.org/0000-0002-2368-1510View further author information
ORCID Icon,
Elizabeth Lydenb Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USAView further author information
,
Utsav Joshic Department of Internal Medicine, Rochester General Hospital, Rochester, NY, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8251-5846View further author information
ORCID Icon,
Avantika Pyakuryald Department of Nursing, Nobel College, Pokhara University, Kathmandu, NepalView further author information
,
Kah Poh Lohe Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USAORCID Iconhttps://orcid.org/0000-0002-6978-0418View further author information
ORCID Icon,
Heidi Klepinf Section on Hematology and Oncology, Department of Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USAView further author information
&
Vijaya Raj Bhattg Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA;h Division of Oncology and Hematology, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USAView further author information
 show all
Pages 691-697 | Received 02 Oct 2022, Accepted 31 Dec 2022, Published online: 11 Jan 2023

References

  • Lehmann S, Ravn A, Carlsson L, et al. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia. 2011;25(7):1128–1134.
  • Park JH, Qiao B, Panageas KS, et al. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood. 2011;118(5):1248–1254.
  • Chen Y, Kantarjian H, Wang H, et al. Acute promyelocytic leukemia: a population‐based study on incidence and survival in the United States, 1975–2008. Cancer. 2012;118(23):5811–5818.
  • Dores GM, Devesa SS, Curtis RE, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood. 2012;119(1):34–43.
  • Dhakal P, Lyden E, Rajasurya V, et al. Early mortality and overall survival in acute promyelocytic leukemia: do real-world data match results of the clinical trials? Leuk Lymphoma. 2021;62(8):1949–1957.
  • Ono T, Takeshita A, Kishimoto Y, et al. Long-term outcome and prognostic factors of elderly patients with acute promyelocytic leukemia. Cancer Sci. 2012;103(11):1974–1978.
  • Dhakal P, Shostrom V, Al-Kadhimi ZS, et al. Usefulness of Charlson comorbidity index to predict early mortality and overall survival in older patients with acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2020;20(12):804.e8–812.e8.
  • Lo-Coco F, Avvisati G, Vignetti M, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013;369(2):111–121.
  • Iland HJ, Bradstock K, Supple SG, et al. All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4). Blood. 2012;120(8):1570–1580; [quiz 1752].
  • Kayser S, Rahmé R, Martínez-Cuadrón D, et al. Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an international collaborative study. Leukemia. 2020;34(9):2333–2341.
  • Debragga S, Simon KS, Kharkhanis P, et al. Comorbid conditions in newly diagnosed patients with acute promyelocytic leukemia (APL) in “real world” patients; decreased induction mortality despite a high comorbid index. Blood. 2017;130:3379.
  • Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–619.
  • About the National Cancer Database; 2017 [cited 2020 Nov 6]. Available from: https://www.facs.org/quality-programs/cancer/ncdb/about
  • Bhatt VR, Shostrom V, Armitage JO, et al. Treatment patterns and outcomes of octogenarian patients with acute myeloid leukemia. Am J Hematol. 2019;94(6):E169–E172.
  • Latagliata R, Breccia M, Fazi P, et al. Long-term results of the GIMEMA LAP AIDA 0493 amended protocol in elderly patients with acute promyelocytic leukemia (APL). Blood. 2005;106:885.
  • Salamero O, Martínez-Cuadrón D, Sobas M, et al. Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry. Leuk Lymphoma. 2019;60(11):2720–2732.
  • Klepin HD, Neuendorff NR, Larson RA, et al. Treatment of acute promyelocytic leukemia in older patients: recommendations of an international society of geriatric oncology (SIOG) task force. J Geriatr Oncol. 2020;11(8):1199–1209.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.